Blood eosinophil counts, withdrawal of inhaled corticosteroids and risk of COPD exacerbations and mortality in the Clinical Practice Research Datalink (CPRD)
O. Oshagbemi (Maastricht, Netherlands), F. Franssen (Maastricht, Netherlands), E. Wouters (Maastricht, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), J. Driessen (Maastricht, Netherlands), A. De Boer (Maastricht, Netherlands), F. Devries (Maastricht, Netherlands), D. Braeken (Maastricht, Netherlands)
Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Oshagbemi (Maastricht, Netherlands), F. Franssen (Maastricht, Netherlands), E. Wouters (Maastricht, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), J. Driessen (Maastricht, Netherlands), A. De Boer (Maastricht, Netherlands), F. Devries (Maastricht, Netherlands), D. Braeken (Maastricht, Netherlands). Blood eosinophil counts, withdrawal of inhaled corticosteroids and risk of COPD exacerbations and mortality in the Clinical Practice Research Datalink (CPRD). 3373
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: